Augmentation with atomoxetine in treatment-resistant depression with psychotic features. A case report

Research output: Contribution to journal › Case report › Contributed › peer-review

Contributors

  • M K Pilhatsch - , Charité – Universitätsmedizin Berlin (Author)
  • R Burghardt - , Charité – Universitätsmedizin Berlin (Author)
  • K-P Wandinger - , Charité – Universitätsmedizin Berlin (Author)
  • M Bauer - , Charité – Universitätsmedizin Berlin (Author)
  • M Adli - , Charité – Universitätsmedizin Berlin (Author)

Details

Original languageEnglish
Pages (from-to)79-80
Number of pages2
JournalPharmacopsychiatry
Volume39
Issue number2
Publication statusPublished - Mar 2006
Peer-reviewedYes
Externally publishedYes

External IDs

Scopus 33645668335
ORCID /0000-0002-2666-859X/work/149438745

Keywords

Keywords

  • Atomoxetine Hydrochloride, Clozapine/therapeutic use, Depressive Disorder, Major/complications, Drug Therapy, Combination, Female, Humans, Middle Aged, Nortriptyline/therapeutic use, Propylamines/therapeutic use, Psychotic Disorders/complications, Recurrence, Selective Serotonin Reuptake Inhibitors/therapeutic use, Severity of Illness Index